The lethal toxicity and lipid peroxidation studies of Alstonia boonei on alloxan induced diabetic rats were analysed. The effect of ethanol leaf extract of A. boonei on the kidney markers of diabetic rat was also determined. The acute toxicity of the ethanol extract of A. boonei was found to be more than 5000 mg/kg body weight of the extract after 24 h of constant observation. The malondialdehyde concentration of the rats treated with 200 and 400 mg/kg body weights of the extract significantly decreased (p<0.05) when compared with the untreated diabetic rats. There was no significant difference (p>0.05) when malondialdehyde concentrations of rat treated with 200 and 400 mg/kg body weights of the extracts were compared with the standard control. But the creatinine concentration decreased significantly (p<0.05) when 200 and 400 mg/kg body weights of the extract of the treated diabetic animals were compared with the diabetic control.
INTRODUCTION
Diabetes mellitus represents a group of metabolic disorders in which there is an impaired glucose utilization inducing hyperglycemia which is an increase in the blood group level beyond normal values (Hazuda, 1991; Adonu et al., 2013) . Diabetes is a chronic disease characterized by elevated blood glucose level and disturbances in carbohydrate, fat and protein metabolism (Sky, 2000; Rother, 2007; Andrew et al., 2013) . In the local markets in West and Central Africa, Alstonia boonei is often among the most common sold plant as crude drugs. Parts of the plant are employed for the treatment of a variety of ailments in Africa and the stem bark has been listed in the Africa Pharmacopoeia as an antimalarial drug (Bello et al ., 2009) .
A. boonei is a popular plant (Figure 1 ). It has many medicinal properties such as antifungal, antibacterial, anti-inflammatory, antiplasmodial, antimalarial, antipyretic, analgesic and hypotensive effects (Olajide et al., 2000) . In this study, acute toxicity of A. boonei ethanol leaf extract and the effects of A. boonei ethanol leaf extract on the kidney markers and lipid peroxidation of diabetic rats were evaluated.
MATERIALS AND METHODS

Materials
Plant materials
Matured leaves of A. boonei were collected in Nsukka environs, Enugu State of Nigeria. The plants were identified and authenticcated by Mr. A. Ozioko of Bioresource Development and Conservation Programme (BDCP) Research Centre, Nsukka, where the voucher specimens were deposited in the herbarium of the Department of Botany, University of Nigeria, Nsukka. (Sidiyasa, 1998) .
Animals
Adult Wistar albino rats of between 10 and 16 weeks with average weight of 160 ± 13 g were obtained from the Animal House of the Faculty of Biological Sciences, University of Nigeria, Nsukka. The animals were acclimatised for 7 days under standard environmental conditions, with a 12 h light/dark cycle maintained on a regular feed (vital feed) and water ad libitum.
Chemicals/reagents/samples
All chemicals used in this study were of analytical grade and products of May and Baker, England; BDH, England and Merck, Darmstadt, Germany. Reagents used for all the assays were commercial kits and products of Randox, USA; Teco (TC), USA; Biosystem Reagents and Instruments, Spain; Glucose Analyzer, Accu Chek Active of Germany; alloxanmonohydrate, Sigma St. Louis, MO, USA.
Instruments/equipment
Water bath (Gallenkamp, England), Chemical Balance (Gallenkamp, England), Conical Flasks (Pyrex, England), Hotbox (Gallenkamp, England), Centrifuge (3,500 rpm, PIC, England), Digital Photo Calorimeter (EI 312 Model, Japan), Adjustable Micropipette (Perfect, U.S.A.), Refrigerator (Kelvinator, Germany), pH Meter (Pye, Unicam 293, England), multi-well microtiter plate reader (Tecan, Austria), Glucose Analyzer, Accu Chek Active of Germany.
Methods
Experimental protocol/design
A total of twenty eight (28) albino Wistar rats were divided into seven (7) groups of four (4) 
Induction of experimental diabetes
Diabetes was induced by intraperitoneal injection of 120 mg/kg body weight of alloxanmonohydrate (Sigma St. Louis, MO, USA) in overnight-fasted animals after acclimatization. Diabetes was confirmed five (5) to eight (8) days later in the alloxan-treated animals showing random blood glucose (RBG) level ≥200mg/dl (11.1 mmol/L). Diabetes status determination was monitored on blood obtained from tail vein puncture using an automated glucose sensor machine GlucometerAnalyser (Accu Chek Active).
Determination of extract yield
The percentage yield of the ethanol extract of leaves of A. boonei was determined by weighing the pulverized leaf powder before extraction and the concentrated extract was obtained after extraction and then calculated using the formula:
Toxicological studies
Acute toxicity and lethality (LD 50 ) test
Acute toxicity (LD 50 ) of the ethanol extract of A. boonei leaves were determined by Lorke's method (1983) . A total of eighteen (18) adult albino mice were used for this investigation. The studies were conducted in two stages. In the first stage, three groups of three mice each were administered (p.o.) 10, 100, 1000 mg/kg body weight of the extract, respectively. The mice were observed for 24 h for a number of death and behavioural changes. In the second stage, based on the percentage survival rates, further increased doses of 1600, 2900 and 5000 mg/kg body weight were administered (p.o.) to three additional mice for each group, respectively, and the fourth mice received only solvent (5% Tween80) which served as the control. The mice were observed for 24 h and the number of deaths was recorded. 
Determination of serum urea concentration
The concentration of serum urea was determined using the method of Tietz (1994) as outlined in Randox kits, UK.
Determination of serum creatinine concentration
The concentration of serum creatinine was determined using the method of Tietz (1994) as outlined in Randox kits, UK.
Determination of lipid peroxidation (malondialdehyde, MDA)
The concentration of malondialdehyde was determined using the method of Draper and Hadley (1990) .
Statistical analysis
Data were reported as means ± SEM, where appropriate. Both oneand two-way analyses of variance (ANOVA) were used to analyse the experimental data and Duncan multiple test range was used to compare the group means obtained after each treatment with control measurements. Differences were considered significant when p ≤ 0.05.
RESULTS
Percentage yield of the extract
From the result in Table 1 , the (%) yield of the ethanol extract of A. boonei leaves was found to be 12.64%.
Acute toxicity studies of Alstonia boonei leaves
The acute toxicity studies (LD 50 ) of the ethanol extract of A. boonei leaves showed that no animal died in any group after receiving increasing doses (between 10 and 5000 mg/kg b.w.) of the ethanol extract of A. boonei leaves ( Table 2) .
Effects of the ethanol extract of Alstonia boonei leaves on urea concentration in normal and diabetic rats
Results in Figure 2 showed neither significant increase nor decrease (p>0.05) in the urea concentration of the diabetic animals administered with 200 mg/kg b.w. of the extract compared with the normal control. Significantly elevated (p<0.05) concentration of urea was observed in the 400 mg/kg b.w of extract treated diabetic rats compared with the normal control. The 200 and 400 mg/kg b.w. of extract treated diabetic animals showed no significant increase or decrease (p>0.05) compared to the diabetic control (group 2) as shown in Figure 2 . The diabetic animals treated with low and high doses of the extract (200 and 400 mg/kg b.w.) showed significant decrease (p<0.05) and increase (p<0.05), respectively, compared with the diabetic animals treated with the standard drug. The normal animals administered low and high doses (200 and 400 mg/kg b.w.) of the extract showed no significant difference compared with the normal and diabetic controls (Groups 1 and 2) as shown in Figure 2 . Interestingly, the 200 mg/kg b.w. treated normal animals showed a significant depreciation (P<0.05) in urea concentration compared with the glibenclamide-treated diabetic animals (standard control).
Effects of ethanol extract of Alstonia Boonei leaves on creatinine concentration in normal and diabetic animals
Creatinine concentration decreased significantly (P<0.05) in the animals treated with low dose (200 mg/kg b.w.) of the extract compared with the standard control as shown in Figure 3 . There was no significant increase or decrease (P>0.05) in the creatinine concentration of both the 200 and 400 mg/kg b.w. treated diabetic animals as compared with the diabetic control. There was, however, a significant increase (p<0.05) in the creatinine concentra- tion of the diabetic animals administered high dose (400 mg/kg b.w.) of the extract compared with the normal control as shown in Figure 3 .
Effects of the ethanol extract of Alstonia Boonei leaves on malondialdehyde (MDA) concentration in normal and diabetic rats
Observation carried out in Figure 4 reveals significant decrease (p<0.05) in the MDA concentration of the diabetic rats treated with low and high (200 and 400 mg/kg b.w.) doses of the extract compared with the diabetic and control (Group 2). There was however no significant difference (p>0.05) in the MDA concentration of these diabetic test animals (Groups 4 and 5) compared with the normal and standard controls. There was a significantly elevated (p<0.05) concentration of MDA in the untreated diabetic rats (Group 2) compared with the rats administered with the standard drug. It is also pertinent to mention that the MDA concentration of the normal rats administered 400 mg/kg b.w. of the extract increased significantly (p<0.05) compared with the normal and standard controls. The normal rats administered 400 mg/kg b.w. of Enechi et al. 681 the extract also showed a significantly elevated (p<0.05) MDA concentration compared with the diabetic rats treated with low and high doses of the extract, and the normal rats administered low dose (200mg/kg) of the extract as shown in Figure 4 .
DISCUSSION
Ayurvedic system of medicine relies on the administration of crude extract or concentration of crude extract of the plant material for the treatment of diabetes mellitus (Salahuddin and Jalalpure, 2010) . Literature survey indicates that there is no scientific evidence to support the antidiabetic effect of A. boonei. Therefore, the present study is undertaken to investigate acute toxicity of A. boonei ethanol leaf extract and the effects of A. boonei ethanol leaf extract on the kidney markers and lipid peroxidation of diabetic rats. In severe diabetic conditions, the kidneys lose their ability to remove wastes products, such as creatinine and urea, from the blood. From the result of the acute toxicity test of the ethanol extract of A. boonei leaves in mice, none of the mice died in any of the groups administered 10, 100, 1000, 1900, 2600 and 5000 mg/kg b.w. of the extract after 24 h. Consequently, it could be suggested that the ethanol extract of A. boonei leaves could be generally regarded as safe (GRAS) (Lorke, 1984) . However, further studies are needed to ascertain the effects of prolonged feeding of high doses of the extract on the organs and tissues of experimental animals. It was also observed that the extract had no reparatory effect on urea and creatinine excretion by the kidney in the diabetic animals since there was no significant difference (p>0.05) in the urea concentration of the treated diabetic animals compared with the diabetic control. Interestingly, the MDA concentration of the 200 and 400 mg/kg b.w. treated diabetic rats showed a significant decrease (p<0.05) compared with the untreated diabetic rats. There was no observed significant difference (p>0.05) in MDA concentration of the treated diabetic rats compared with the standard control. This shows that the extract was able to prevent lipid peroxidation by reducing the action of the alloxan-induced free radicals. Consequently, the ethanol concentration of A. boonei leaves has a potential antioxidant activity which can be a possible mechanism of its antidiabetic action. The flavonoids (antioxidants and free radical scavengers) in this plant may contribute to the effect of the plant extract in reducing MDA concentration and concomitant lipid peroxidetion (Afolabi et al., 2007) . The capacity of flavonoids to act as antioxidants depends on their molecular structure. The position of hydroxyl groups and other features in the chemical structure of flavonoids are important for their antioxidant and free radical scavenging activities. Quercetin, the most abundant dietary flavonol, is a potent antioxidant because it has all the right structural features for free radical scavenging activity (Frei, 2006) .
Conclusion
In conclusion, the ethanol leaf extract of A. boonei has been shown to prevent lipid peroxidation and at the same time had no reparatory effects on the kidney markers. This prevention of lipid peroxidation could be the reason ethanol extracts of A. boonei leaf have been used in numerous ethnomedicinal practices in combating ailments.
